Corrigendum to “Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity” (Eur. J. Med. Chem. (2012) 55 (220–227)(S0223523412004497)(10.1016/j.ejmech.2012.07.023))

Kuen Feng Chen; Wei Tien Tai; Cheng Yi Hsu; Jui Wen Huang; Chun Yu Liu; Pei Jer Chen; In Ki Kim; Chung Wai Shiau

doi:10.1016/j.ejmech.2017.10.053

Corrigendum to “Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity” (Eur. J. Med. Chem. (2012) 55 (220–227)(S0223523412004497)(10.1016/j.ejmech.2012.07.023))

Kuen Feng Chen, Wei Tien Tai, Cheng Yi Hsu, Jui Wen Huang, Chun Yu Liu, Pei Jer Chen, In Ki Kim, Chung Wai Shiau^*

^*此作品的通信作者

研究成果: Comment/debate

1 引文斯高帕斯（Scopus）

摘要

The authors regret for the mistake occurred in Figure 6B. The corrected figure is shown below. The result and conclusions in the article remain unchanged. The authors would like to apologise for any inconvenience caused.

原文	English
頁（從 - 到）	2015
頁數	1
期刊	European Journal of Medicinal Chemistry
卷	143
DOIs	https://doi.org/10.1016/j.ejmech.2017.10.053
出版狀態	Published - 1 1月 2018

存取文件

10.1016/j.ejmech.2017.10.053

其它文件與鏈接

Link to publication in Scopus

引用此

Chen, K. F., Tai, W. T., Hsu, C. Y., Huang, J. W., Liu, C. Y., Chen, P. J., Kim, I. K., & Shiau, C. W. (2018). Corrigendum to “Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity” (Eur. J. Med. Chem. (2012) 55 (220–227)(S0223523412004497)(10.1016/j.ejmech.2012.07.023)). European Journal of Medicinal Chemistry, 143, 2015. https://doi.org/10.1016/j.ejmech.2017.10.053

@article{214a28b1d21343d1a1497bae9bfecec1,

title = "Corrigendum to “Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity” (Eur. J. Med. Chem. (2012) 55 (220–227)(S0223523412004497)(10.1016/j.ejmech.2012.07.023))",

abstract = "The authors regret for the mistake occurred in Figure 6B. The corrected figure is shown below. The result and conclusions in the article remain unchanged. The authors would like to apologise for any inconvenience caused.",

author = "Chen, {Kuen Feng} and Tai, {Wei Tien} and Hsu, {Cheng Yi} and Huang, {Jui Wen} and Liu, {Chun Yu} and Chen, {Pei Jer} and Kim, {In Ki} and Shiau, {Chung Wai}",

note = "Publisher Copyright: {\textcopyright} 2017 Elsevier Masson SAS",

year = "2018",

month = jan,

day = "1",

doi = "10.1016/j.ejmech.2017.10.053",

language = "English",

volume = "143",

pages = "2015",

journal = "European Journal of Medicinal Chemistry",

issn = "0223-5234",

publisher = "Elsevier Masson s.r.l.",

}

Chen, KF, Tai, WT, Hsu, CY, Huang, JW, Liu, CY, Chen, PJ, Kim, IK & Shiau, CW 2018, 'Corrigendum to “Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity” (Eur. J. Med. Chem. (2012) 55 (220–227)(S0223523412004497)(10.1016/j.ejmech.2012.07.023))', European Journal of Medicinal Chemistry, 卷 143, 頁 2015. https://doi.org/10.1016/j.ejmech.2017.10.053

TY - JOUR

T1 - Corrigendum to “Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity” (Eur. J. Med. Chem. (2012) 55 (220–227)(S0223523412004497)(10.1016/j.ejmech.2012.07.023))

AU - Chen, Kuen Feng

AU - Tai, Wei Tien

AU - Hsu, Cheng Yi

AU - Huang, Jui Wen

AU - Liu, Chun Yu

AU - Chen, Pei Jer

AU - Kim, In Ki

AU - Shiau, Chung Wai

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The authors regret for the mistake occurred in Figure 6B. The corrected figure is shown below. The result and conclusions in the article remain unchanged. The authors would like to apologise for any inconvenience caused.

AB - The authors regret for the mistake occurred in Figure 6B. The corrected figure is shown below. The result and conclusions in the article remain unchanged. The authors would like to apologise for any inconvenience caused.

UR - http://www.scopus.com/inward/record.url?scp=85032826314&partnerID=8YFLogxK

U2 - 10.1016/j.ejmech.2017.10.053

DO - 10.1016/j.ejmech.2017.10.053

M3 - Comment/debate

C2 - 29113744

AN - SCOPUS:85032826314

SN - 0223-5234

VL - 143

SP - 2015

JO - European Journal of Medicinal Chemistry

JF - European Journal of Medicinal Chemistry

ER -

Corrigendum to “Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity” (Eur. J. Med. Chem. (2012) 55 (220–227)(S0223523412004497)(10.1016/j.ejmech.2012.07.023))

摘要

存取文件

其它文件與鏈接

指紋

引用此